Fig. 3. Effects of the high, intermediate, and low Torsades de Pointes risk drugs on action potential (AP) waveforms in human induced pluripotent stem cell-derived cardiomyocytes.
Representative ventricular-type AP traces in the control and in the presence of 14.69 μM sotalol (A), 0.03 μM chlorpromazine (B), and 2.5 μM mexiletine (C).
© Korean J Physiol Pharmacol
